Your browser doesn't support javascript.
loading
Outreach to diversify clinical trial participation: A randomized recruitment study.
Brown, Susan D; Partee, Paula N; Feng, Juanran; Quesenberry, Charles P; Hedderson, Monique M; Ehrlich, Samantha F; Kiernan, Michaela; Ferrara, Assiamira.
Afiliação
  • Brown SD; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA susan.d.brown@kp.org.
  • Partee PN; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Feng J; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Quesenberry CP; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Hedderson MM; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Ehrlich SF; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Kiernan M; Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA, USA.
  • Ferrara A; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Clin Trials ; 12(3): 205-11, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25644997
ABSTRACT
BACKGROUND/

AIMS:

Racial and ethnic minorities remain underrepresented in clinical research, yet few recruitment strategies have been rigorously evaluated.

METHODS:

We experimentally tested whether targeted recruitment letters acknowledging diabetes health disparities and health risks specific to recipients' racial/ethnic group improved two metrics of trial participation willingness to be screened and enrollment. This experiment was efficiently nested within a randomized clinical trial examining a preventive lifestyle intervention among women at high risk for diabetes. Pregnant women with gestational diabetes or impaired glucose tolerance (N = 445) were randomized to receive a targeted recruitment letter with health risk information specific to their racial/ethnic group (n = 216), or a standard letter with risk information for the general population (n = 229). All letters were bilingual in English and Spanish.

RESULTS:

The targeted as compared to the standard letter did not improve screening or enrollment rates overall or within separate racial/ethnic groups. Among Latina women who preferred Spanish, the targeted letter showed trends for improved screening (66.7% vs 33.3%, p = .06) and enrollment rates (38.9% vs 13.3%, p = .13). In contrast, among Latina women who preferred English, the targeted letter significantly lowered screening (29.6% vs 57.1%, p = .04) and showed trends for lowered enrollment rates (25.9% vs 50.0%, p = .07).

CONCLUSION:

Results from this randomized study appear to suggest that recruitment letters with diabetes health risk information targeted to recipients' race/ethnicity may improve one metric of clinical trial participation among Latina women who prefer Spanish, but not English. Larger experimental studies, incorporating input from diverse participant stakeholders, are needed to develop evidence-based minority recruitment strategies.
Assuntos
Palavras-chave

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Hispânico ou Latino / Diabetes Gestacional / Intolerância à Glucose / Seleção de Pacientes / Idioma Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Hispânico ou Latino / Diabetes Gestacional / Intolerância à Glucose / Seleção de Pacientes / Idioma Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2015 Tipo de documento: Article